Chris Valosky serves as Vice President, Sales for Pear Therapeutics, responsible for leading Pear’s sales organization. He comes to Pear with more than 20 years of commercial biopharmaceutical experience across sales leadership and brand marketing within neuroscience, endocrinology, cardiology, and oncology.
Prior to Pear, he served as Senior Director, Marketing at Takeda where he spent 15 years in roles of increasing responsibility in sales, sales training, brand marketing and multichannel marketing. During his tenure, he was recognized for developing innovative strategies, executing on commercial priorities, and leading teams to successful customer engagement focused on improving patient outcomes. Earlier in this career, Chris spent six years at Eli Lilly and Company in senior marketing and sales roles.
Chris earned his MBA from Indiana University, Kelley School of Business, and his Bachelor of Science in Business Administration, Marketing from The Ohio State University.